A key aspect of our studies is the direct, serial and simultaneous visualization and assessment of both implanted tumor cells and host blood vessels to show that endogenous erythropoietin is a critical factor involved in the attraction of new capillaries to vascularize the expanding tumor mass. This evidence concerns the gene EPO and neoplasm.